 | • レポートコード：MRC2304D136 • 出版社/出版日：Transparency Market Research / 2023年1月24日 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、急性肺損傷治療の世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、治療法別（機械的換気、薬物療法、輸液管理、その他）分析、エンドユーザー別（病院、専門センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを収録しています。また、Mayo Clinic、Johns Hopkins Hospital、Cleveland Clinic、Great Ormond Street Hospital、Apollo Hospitals、Tokyo Medical University Hospital、The Prince Charles Hospital、Helios Hospital、Aster Hospitalsなどの企業情報を掲載しています。 ・序論 ・仮定＆調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の急性肺損傷治療市場規模：治療法別 - 機械的換気治療の市場規模 - 薬物療法の市場規模 - 輸液管理治療の市場規模 - その他治療法の市場規模 ・世界の急性肺損傷治療市場規模：エンドユーザー別 - 病院における市場規模 - 専門センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の急性肺損傷治療市場規模：地域別 - 北米の急性肺損傷治療市場規模 - ヨーロッパの急性肺損傷治療市場規模 - アジア太平洋の急性肺損傷治療市場規模 - 中南米のアルミニウムスラグ市場規模 - 中東・アフリカのアルミニウムスラグ市場規模 ・競争状況 |
Acute Lung Injury Treatment Market – Scope of Report
TMR’s report on the global acute lung injury treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global acute lung injury treatment market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute lung injury treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the acute lung injury treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute lung injury treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global acute lung injury treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute lung injury treatment market.
The report delves into the competitive landscape of the global acute lung injury treatment market. Key players operating in the global acute lung injury treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global acute lung injury treatment market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market acute lung injury treatment.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Acute Lung Injury Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Acute Lung Injury Treatment Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projection (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Therapy
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapy, 2017 – 2031
6.3.1. Mechanical Ventilation
6.3.2. Pharmacotherapy
6.3.3. Fluid Management
6.3.4. Others
6.4. Market Attractiveness, by Therapy
7. Global Acute Lung Injury Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017 – 2031
7.3.1. Hospitals
7.3.2. Specialty Centers
7.3.3. Others
7.4. Market Attractiveness, by End-user
8. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Acute Lung Injury Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Therapy, 2017 – 2031
9.2.1. Mechanical Ventilation
9.2.2. Pharmacotherapy
9.2.3. Fluid Management
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2017 – 2031
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017 – 2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Therapy
9.5.2. By End-user
9.5.3. By Country
10. Europe Acute Lung Injury Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Therapy, 2017 – 2031
10.2.1. Mechanical Ventilation
10.2.2. Pharmacotherapy
10.2.3. Fluid Management
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2017 – 2031
10.3.1. Hospitals
10.3.2. Specialty Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017 – 2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Therapy
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Acute Lung Injury Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Therapy, 2017 – 2031
11.2.1. Mechanical Ventilation
11.2.2. Pharmacotherapy
11.2.3. Fluid Management
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2017 – 2031
11.3.1. Hospitals
11.3.2. Specialty Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017 – 2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Therapy
11.5.2. By End-user
11.5.3. By Country/sub-region
12. Latin America Acute Lung Injury Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapy, 2017 – 2031
12.2.1. Mechanical Ventilation
12.2.2. Pharmacotherapy
12.2.3. Fluid Management
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2017 – 2031
12.3.1. Hospitals
12.3.2. Specialty Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Therapy
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Acute Lung Injury Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapy, 2017 – 2031
13.2.1. Mechanical Ventilation
13.2.2. Pharmacotherapy
13.2.3. Fluid Management
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2017 – 2031
13.3.1. Hospitals
13.3.2. Specialty Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Therapy
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis By Company (2021)
14.3. Company Profiles
14.3.1. Mayo Clinic
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Business Strategies
14.3.1.5. Recent Developments
14.3.2. Johns Hopkins Hospital
14.3.2.1. Company Overview
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. Business Strategies
14.3.2.5. Recent Developments
14.3.3. Cleveland Clinic
14.3.3.1. Company Overview
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. Business Strategies
14.3.3.5. Recent Developments
14.3.4. Great Ormond Street Hospital
14.3.4.1. Company Overview
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. Business Strategies
14.3.4.5. Recent Developments
14.3.5. Apollo Hospitals
14.3.5.1. Company Overview
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. Business Strategies
14.3.5.5. Recent Developments
14.3.6. Tokyo Medical University Hospital
14.3.6.1. Company Overview
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. Business Strategies
14.3.6.5. Recent Developments
14.3.7. The Prince Charles Hospital
14.3.7.1. Company Overview
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. Business Strategies
14.3.7.5. Recent Developments
14.3.8. Helios Hospital
14.3.8.1. Company Overview
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. Business Strategies
14.3.8.5. Recent Developments
14.3.9. Aster Hospitals
14.3.9.1. Company Overview
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. Business Strategies
14.3.9.5. Recent Developments